European Retinoblastoma Meeting Group 2024 Highlights

In an interview with Dr. Lauren Dalvin, European Retinablastoma Meeting Group (EURBG) 2024 coordinator Dr. Maria Pefkianaki discusses the importance of developing Greece's first retinablastoma center and highlights key aspects of the EURBG 2024 program. This year's EURBG meeting is a 3-day collaboration with the Ocular Oncology Happy Hour Symposium, with the first day focused on a variety of topics in ocular oncology followed by 2 days devoted to retinablastoma in recognition of the opening of the new retinablastoma center. 

Financial Disclosures: Dr. Lauren Dalvin discloses financial relationships with Ideaya Biosciences (Consultant/Advisor); Leonard and Mary Lou Hoeft Career Development Award Fund, National Cancer Institute, National Center for Advancing Translational Sciences (Grant Support). Dr. Maria Pefkianakis discloses no financial relationships.